ERBB2 and breast ductal adenocarcinoma: HER-2 is overexpressed in several subtypes of salivary gland carcinomas (ductal carcinoma: 43%; ex pleomorphic adenoma carcinoma: 39%; NOS adenocarcinoma: 13%; and mucoepidermoid carcinoma: 5%) [54].